Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Fallopian Tube Neoplasms × atezolizumab × Clear all

Phase

Phase 3 1 Phase 2/3 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 51 Carcinoma, Hepatocellular 27 Breast Neoplasms 24 Small Cell Lung Carcinoma 18 Triple Negative Breast Neoplasms 17 Lung Neoplasms 16 Urinary Bladder Neoplasms 14 Neoplasms 14 Neoplasm Metastasis 14 Melanoma 14 Carcinoma, Transitional Cell 14 Colorectal Neoplasms 13 Uterine Cervical Neoplasms 9 Head and Neck Neoplasms 7 Carcinoma, Renal Cell 7 Stomach Neoplasms 6 Recurrence 6 Prostatic Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Sarcoma 5 Mesothelioma, Malignant 5 Liver Neoplasms 5 Carcinoma, Squamous Cell 5 Ovarian Neoplasms 4 Carcinoma, Merkel Cell 4 Thoracic Neoplasms 3 Solid Tumors 3 Rectal Neoplasms 3 Lymphoma, Follicular 3 Lymphoma 3

Interventions

Carboplatin 50 Paclitaxel 44 Bevacizumab 32 Gemcitabine 18 pembrolizumab 15 Taxes 12 olaparib 11 Cisplatin 11 Immunoglobulin G 10 Disulfides 10 Topotecan 9 niraparib 8 Cyclophosphamide 7 Specimen Handling 6 Biopsy 6 mirvetuximab soravtansine 5 Nivolumab 5 Letrozole 5 Drug Therapy 5 Docetaxel 5 Cytoreduction Surgical Procedures 5 Albumin-Bound Paclitaxel 5 rucaparib 4 oregovomab 4 liposomal doxorubicin 4 Surgical Procedures, Operative 4 Neoadjuvant Therapy 4 Magnetic Resonance Spectroscopy 4 Hyperthermic Intraperitoneal Chemotherapy 4 Granulocyte-Macrophage Colony-Stimulating Factor 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03363867 2023-08-07

BEACON

Peter MacCallum Cancer Centre, Australia

Phase 2 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡